Published online before print July 29, 2004, doi: 10.1161/01.STR.0000138784.68159.a5
(Stroke. 2004;35:2036.)
© 2004 American Heart Association, Inc.
Original Contributions |
Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor 
Associated With Carotid Atherosclerosis
From the Robarts Research Institute (K.Z.A.-S., H.M.R.K., A.F., J.D.S., R.A.H.), London, Ontario, Canada; the Department of Medicine (A.A.H.), University of Western Ontario, London, Ontario, Canada; the Department of Medicine and Samuel Lunenfeld Research Institute (A.J.G.H., B.Z.), Mount Sinai Hospital and University of Toronto, Ontario, Canada; the Thames Valley Family Practice Research Unit (S.B.H.), University of Western Ontario, London, Ontario, Canada; and the Sandy Lake Health and Diabetes Project (M.M.), Ontario, Canada.
Correspondence to Dr Robert A. Hegele, Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406-100 Perth Dr, London, Ontario, Canada N6A 5K8. E-mail hegele{at}robarts.ca
Background and Purpose— Peroxisome proliferator-activated receptor 
is a crucial molecule in atherogenesis because it is associated with metabolic risk factors such as obesity and diabetes and also plays a key role in subcellular metabolism of arterial wall macrophage foam cells. Genetic variation in PPARG has been associated with metabolic and cardiovascular end points.
Methods— We investigated the relationship between 2 common PPARG polymorphisms, namely P12A and c.1431C>T, and carotid atherosclerosis in a sample of 161 Canadian aboriginal people. Dependent variables were carotid intima media thickness (IMT), assessed using B-mode ultrasonography, and total carotid plaque volume (TPV), assessed using 3D ultrasound.
Results— Using multivariate analysis, we found that subjects with 
1 PPARG A12 allele had less carotid IMT than others (0.72±0.03 versus 0.80±0.02 mm; P=0.0045), with no between-genotype difference in TPV. In contrast, subjects with the PPARG c.1431T allele had greater TPV than others (124±18.4 versus 65.1±23.7 mm3; P=0.0079), with no between-genotype difference in IMT.
Conclusions— The findings show an association between PPARG genotypes and carotid arterial phenotypes, and further reflect the prevailing view that the PPARG A12 allele protects against deleterious phenotypes. Also, whereas IMT and TPV are somewhat correlated with each other, they might also represent distinct traits with discrete determinants representing different stages of atherogenesis.
Key Words: atherosclerosis • carotid arteries • polymorphism • ultrasonography
This article has been cited by other articles:
 |
|
 |
|
  J. J. Regieli, J. W. Jukema, P. A. Doevendans, A. H. Zwinderman, Y. van der Graaf, J. J. Kastelein, and D. E. Grobbee PPAR{gamma} Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease Patients Diabetes Care, May 1, 2009; 32(5): 839 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Egger, A. Krasinski, B. K. Rutt, A. Fenster, and G. Parraga Comparison of B-Mode Ultrasound, 3-Dimensional Ultrasound, and Magnetic Resonance Imaging Measurements of Carotid Atherosclerosis J. Ultrasound Med., September 1, 2008; 27(9): 1321 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Musaad and E. N. Haynes Biomarkers of Obesity and Subsequent Cardiovascular Events Epidemiol. Rev., May 10, 2007; (2007) mxm005v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Iglseder, H. Oberkofler, T. K. Felder, K. Klein, B. Paulweber, F. Krempler, D. A. Tregouet, and W. Patsch Associations of PPARGC1A Haplotypes With Plaque Score but Not With Intima-Media Thickness of Carotid Arteries in Middle-Aged Subjects Stroke, September 1, 2006; 37(9): 2260 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hegele, K. Z. Al-Shali, A. A. House, A. J.G. Hanley, S. B. Harris, M. Mamakeesick, A. Fenster, B. Zinman, H. Cao, and J. D. Spence Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits Stroke, December 1, 2005; 36(12): 2566 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pischon, J. K. Pai, J. E. Manson, F. B. Hu, K. M. Rexrode, D. Hunter, and E. B. Rimm Peroxisome Proliferator-Activated Receptor-{gamma}2 P12A Polymorphism and Risk of Coronary Heart Disease in US Men and Women Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1654 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Ruiz-Narvaez Is the Ala12 variant of the PPARG gene an "unthrifty allele"? J. Med. Genet., July 1, 2005; 42(7): 547 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oberkofler, B. Iglseder, K. Klein, J. Unger, M. Haltmayer, F. Krempler, B. Paulweber, and W. Patsch Associations of the UCP2 Gene Locus With Asymptomatic Carotid Atherosclerosis in Middle-Aged Women Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 604 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S.F. Doney, B. Fischer, G. Leese, A. D. Morris, and C. N.A. Palmer Cardiovascular Risk in Type 2 Diabetes Is Associated With Variation at the PPARG Locus: A Go-DARTS Study Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2403 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Spence, R. A. Hegele, T. Manolio, E. Boerwinkle, C. O'Donnell, and A. F. Wilson Noninvasive Phenotypes of Atherosclerosis Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): e188 - e189. [Full Text] [PDF]
|
|